Enanta Pharmaceuticals, Inc. (ENTA) vs Opus Genetics, Inc. (IRD)
- Enanta Pharmaceuticals, Inc. ENTA 11.10 −3.23%
- Opus Genetics, Inc. IRD 3.81 −5.93%
Enanta Pharmaceuticals, Inc. and Opus Genetics, Inc. are both Biotechnology companies. Enanta Pharmaceuticals, Inc. and Opus Genetics, Inc. are of similar size ($336.9M and $334.1M). Enanta Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 0.70% against −36.1%. Enanta Pharmaceuticals, Inc. has the higher net margin (−96.9% vs −1,091.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Enanta Pharmaceuticals, Inc. leads on 10 and Opus Genetics, Inc. on 4.
Valuation
Profitability
| Metric | ENTA | IRD | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (89.99%) | (513.47%) | 0.00% |
| Net margin | (96.89%) | (1,091.82%) | 0.00% |
| Free cash flow margin | (56.60%) | (412.61%) | 0.00% |
| Return on equity | (70.12%) | (4,796.52%) | (56.36%) |
| Return on assets | (21.15%) | (163.50%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack